This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.
Fungalite is a structured two-phase approach. Phase I provides four botanical antimicrobials, garlic (188mg, for allicin), olive leaf extract (188mg, 38mg oleuropein), grapefruit seed extract (57mg) and oregano extract (50mg, supplying carvacrol and thymol), chosen because laboratory studies show they act on yeasts through different mechanisms, which makes microbial resistance to the combination less likely than to any single agent. Phase II follows with caprylic acid from medium-chain triglycerides. Laboratory evidence for these compounds against Candida species is consistent; human trial evidence for supplement protocols is limited, and the entry says so plainly. Each phase is a 22-day supply taken in sequence.
The Phase I agents act on microbes through different routes in laboratory studies. Allicin from garlic reacts with thiol groups on microbial enzymes and disrupts membranes, inhibiting Candida species in vitro at minimum inhibitory concentrations of roughly 1.6 to 6.3 micrograms per millilitre. Carvacrol and thymol from oregano disrupt fungal cell membrane integrity. Oleuropein and grapefruit seed extract add further membrane-active polyphenols. Using several mechanisms at once is a resistance-management strategy borrowed from clinical practice.
There is no authorised or clinically standardised human dose for botanical antifungal protocols, which is worth stating plainly. The doses here, 188mg garlic and olive leaf, 57mg grapefruit seed and 50mg oregano extract per capsule, sit in the ranges typical of practitioner protocols, and the laboratory concentrations shown to inhibit yeasts do not translate directly into oral doses. The two-phase, time-boxed structure exists precisely because these are short-course tools, not open-ended daily supplements.
The protocol runs as two capsule products taken in sequence. Phase I capsules provide 188mg garlic powder, 188mg olive leaf extract standardised to 38mg oleuropein, 57mg grapefruit seed extract and 50mg oregano extract from Origanum vulgare leaf, in a vegetarian shell. Phase II moves to medium-chain triglycerides including caprylic acid. Each phase is a 22-day supply at the directed dose, giving the full protocol a roughly six-week arc.
Phase I comes first and Phase II follows it; the sequence is the design, with the antimicrobial phase preceding the maintenance phase. Capsules are taken with food, which improves tolerability for pungent botanicals like garlic and oregano. The product guidance pairs the protocol with activated charcoal, a traditional binding approach during antimicrobial phases. Probiotic reintroduction typically follows the protocol rather than running through it, so the new strains are not arriving mid-antimicrobial.
The botanicals are widely used and generally well tolerated at these doses, with digestive warmth or garlic odour the common experiences. Not for use in pregnancy or breastfeeding, since concentrated botanical antimicrobials lack safety data in those groups. Persistent digestive symptoms, thrush that keeps returning, or systemic symptoms such as fever are reasons to see a GP first, because self-directed protocols are not a substitute for investigating what is wrong.
Not for pregnancy or breastfeeding. Anyone on anticoagulants, antiplatelets, or with surgery scheduled should take clinical advice before concentrated garlic. People with ragweed-family allergies can cross-react with some botanicals. Immunocompromised people with suspected fungal issues need clinical care, not a supplement protocol; that situation is outside what any botanical product addresses.
Garlic compounds have mild antiplatelet activity in laboratory studies, so anyone on anticoagulant or antiplatelet therapy should take clinical advice before concentrated garlic products, and the same applies ahead of surgery. Grapefruit seed extract is not grapefruit juice and the classic enzyme interaction is not established for it, but caution is reasonable for anyone whose prescriptions carry grapefruit warnings. Nutri365 checks for interactions and contraindications across a full supplement and lifestyle picture when you use the platform.
None of the Phase I botanicals holds an authorised GB or EU health claim; botanical claims remain on hold in both registers. The laboratory evidence base is real and consistent, allicin inhibits Candida, Cryptococcus and dermatophyte species in vitro at low micrograms per millilitre, and reviews note that in vivo human documentation has not caught up with the in vitro results. That gap between laboratory and clinical evidence is the fair frame for the whole category.
Fungalite suits someone who has decided, ideally with a practitioner, to run a structured botanical protocol rather than take single ingredients ad hoc: Phase I then Phase II, 22 days each, with food, charcoal alongside if following the product guidance, and probiotics after. Fungalite Phase I and Phase II are UK-made and in stock at nutritailor.co.uk. Anyone with recurrent or systemic symptoms should start with a GP rather than a protocol, and pregnancy rules the protocol out.
Laboratory inhibition of Candida does not equal a clinical result, and this entry makes no eradication claims; the in vitro to in vivo gap is the defining limit of the category. Candida overgrowth is also not the explanation for most fatigue and bloating, despite what much of the internet says, which is why investigation beats assumption. And stronger is not better with botanical antimicrobials; the doses and the time-box exist because these are potent compounds used briefly, not dailies.